BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32640944)

  • 21. Low- Versus Standard-Dose Alteplase in Patients on Prior Antiplatelet Therapy: The ENCHANTED Trial (Enhanced Control of Hypertension and Thrombolysis Stroke Study).
    Robinson TG; Wang X; Arima H; Bath PM; Billot L; Broderick JP; Demchuk AM; Donnan GA; Kim JS; Lavados PM; Lee TH; Lindley RI; Martins SCO; Olavarria VV; Pandian JD; Parsons MW; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Nguyen TH; Wang JG; Woodward M; Chalmers J; Anderson CS;
    Stroke; 2017 Jul; 48(7):1877-1883. PubMed ID: 28619989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving Visualization Methods of Utility-Weighted Disability Outcomes for Stroke Trials.
    Tokunboh I; Sung EM; Chatfield F; Gaines N; Nour M; Starkman S; Saver JL
    Front Neurol; 2022; 13():875350. PubMed ID: 35645952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient-Reported Quality of Life After Intravenous Alteplase for Stroke in the WAKE-UP Trial.
    Jensen M; Sehner S; Cheng B; Schlemm E; Quandt F; Barow E; Wegscheider K; Boutitie F; Ebinger M; Endres M; Fiebach JB; Thijs V; Lemmens R; Muir KW; Nighoghossian N; Pedraza S; Simonsen CZ; Thomalla G; Gerloff C
    Neurology; 2023 Jan; 100(2):e154-e162. PubMed ID: 36302662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health State Utility Values in People With Stroke: A Systematic Review and Meta-Analysis.
    Joundi RA; Adekanye J; Leung AA; Ronksley P; Smith EE; Rebchuk AD; Field TS; Hill MD; Wilton SB; Bresee LC
    J Am Heart Assoc; 2022 Jul; 11(13):e024296. PubMed ID: 35730598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving the reliability of stroke disability grading in clinical trials and clinical practice: the Rankin Focused Assessment (RFA).
    Saver JL; Filip B; Hamilton S; Yanes A; Craig S; Cho M; Conwit R; Starkman S;
    Stroke; 2010 May; 41(5):992-5. PubMed ID: 20360551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
    Wong CKH; Lang BHH; Yu HMS; Lam CLK
    Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracluster correlation coefficients and reliability of randomized multicenter stroke trials within VISTA.
    Frank B; Fulton RL; Goldie FC; Hacke W; Weimar C; Lees KR;
    Int J Stroke; 2014 Jul; 9(5):602-6. PubMed ID: 24015969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis.
    Banks JL; Marotta CA
    Stroke; 2007 Mar; 38(3):1091-6. PubMed ID: 17272767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Value-based healthcare in ischemic stroke care: case-mix adjustment models for clinical and patient-reported outcomes.
    Oemrawsingh A; van Leeuwen N; Venema E; Limburg M; de Leeuw FE; Wijffels MP; de Groot AJ; Hilkens PHE; Hazelzet JA; Dippel DWJ; Bakker CH; Voogdt-Pruis HR; Lingsma HF
    BMC Med Res Methodol; 2019 Dec; 19(1):229. PubMed ID: 31805876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Agreement between 30-day and 90-day modified Rankin Scale score and utility-weighted modified Rankin Scale score in acute intracerebral hemorrhage: An analysis of ATACH-2 trial data.
    Coleman CI; Concha M; Baker WL; Koch B; Lovelace B; Christoph MJ; Cohen AT
    J Clin Neurosci; 2024 Mar; 121():61-66. PubMed ID: 38364727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient-reported, health-related, quality of life after stroke thrombectomy in clinical practice.
    Deb-Chatterji M; Konnopka A; Flottmann F; Leischner H; Fiehler J; Gerloff C; Thomalla G
    Neurology; 2020 Sep; 95(12):e1724-e1732. PubMed ID: 32680947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of home rehabilitation program for ischemic stroke upon disability and quality of life: a randomized controlled trial.
    Chaiyawat P; Kulkantrakorn K
    Clin Neurol Neurosurg; 2012 Sep; 114(7):866-70. PubMed ID: 22321758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mapping of the DLQI scores to EQ-5D utility values using ordinal logistic regression.
    Ali FM; Kay R; Finlay AY; Piguet V; Kupfer J; Dalgard F; Salek MS
    Qual Life Res; 2017 Nov; 26(11):3025-3034. PubMed ID: 28601958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construct validity and reliability of EQ-5D-3L for stroke survivors in a lower middle income setting.
    Mahesh PKB; Gunathunga MW; Jayasinghe S; Arnold SM; Senanayake S; Senanayake C; De Silva LSD; Kularatna S
    Ceylon Med J; 2019 Jun; 64(2):52-58. PubMed ID: 31455067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect Size Estimates for the ESCAPE Trial: Proportional Odds Regression Versus Other Statistical Methods.
    Sajobi TT; Zhang Y; Menon BK; Goyal M; Demchuk AM; Broderick JP; Hill MD
    Stroke; 2015 Jul; 46(7):1800-5. PubMed ID: 26022639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initial testing of an electronic application of the simplified modified Rankin Scale questionnaire (e-smRSq).
    Dutta D; Foy C; Ramadurai G; Obaid M; Bruno A
    J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105024. PubMed ID: 32807439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimizing cutoff scores for the Barthel index and the modified Rankin scale for defining outcome in acute stroke trials.
    Uyttenboogaart M; Stewart RE; Vroomen PC; De Keyser J; Luijckx GJ
    Stroke; 2005 Sep; 36(9):1984-7. PubMed ID: 16081854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison Between the Original and Shortened Versions of the National Institutes of Health Stroke Scale in Ischemic Stroke Patients of Intermediate Severity.
    Lee CF; Venketasubramanian N; Wong KS; Chen CL;
    Stroke; 2016 Jan; 47(1):236-9. PubMed ID: 26628386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modest association between the discharge modified Rankin Scale score and symptomatic intracerebral hemorrhage after intravenous thrombolysis.
    Asuzu D; Nystrom K; Amin H; Schindler J; Wira C; Greer D; Chi NF; Halliday J; Sheth KN
    J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):548-53. PubMed ID: 25540072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.